FDA examines dialysis equipment contamination:
This article was originally published in Clinica
The FDA is examining reports of blood contamination in internal parts of dialysis equipment at several centres in the US. It is not yet clear how the contamination happened, but the agency warned that it is possible that blood borne pathogens could be transmitted from patient to patient. Since December 1998, several incidents of blood contamination during haemodialysis have occurred, according to a safety alert sent to dialysis centres and hospitals by the FDA's Center for Devices and Radiological Health.